Form 4 Tracker
Matt Zuga

CFO & Chief Business Officer · 2 filings · Latest: Jan 21, 2026

Acumen Pharmaceuticals, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
ABOS
Matt ZugaCFO & Chief Business OfficerJan 22, 2026
Sale
$1.861,687$3.1K304,924
ABOS
Matt ZugaCFO & Chief Business OfficerJan 21, 2026
Sale
$1.812,473$4.5K306,611
ABOS
Zuga MattJan 22, 2026
Proposed Sale
$1.861,687$3.1K
ABOS
Zuga MattJan 21, 2026
Proposed Sale
$1.812,473$4.5K
ABOS
Zuga MattJan 8, 2026
Proposed Sale
$1.826,888$12.5K
ABOS
Zuga MattJan 7, 2026
Proposed Sale
$1.995,805$11.6K
ABOS
Zuga MattJan 6, 2026
Proposed Sale
$1.975,100$10.0K
ABOS
Zuga MattJan 5, 2026
Proposed Sale
$1.964,000$7.8K
ELUT
William Matthew ZugaDec 23, 2025
Proposed Sale
$0.5512,613$6.9K
ABOS
Zuga MattJan 23, 2025
Proposed Sale
$1.7228,902$49.6K
ABOS
Zuga MattJan 21, 2025
Proposed Sale
$1.604,364$7.0K
ABOS
Zuga MattJan 3, 2025
Proposed Sale
$1.8413,235$24.4K